Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation

Neurochemistry International

Volumn 117, Issue , 2018, Pages 174-187

  Vidoni, Chiara ^a   Secomandi, Eleonora ^a   Castiglioni, Andrea ^a   Melone, Mariarosa A B ^b   Isidoro, Ciro ^a,b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Anti oxidant; Autophagy; Dopaminergic neurons; Huntington; Neurodegeneration; Parkinson

Indexed keywords

CYSTEINE; DOPAMINE; HUNTINGTIN; PROTEIN ATG4; RESVERATROL; UNCLASSIFIED DRUG; ANTIOXIDANT; ATG4A PROTEIN, HUMAN; AUTOPHAGY RELATED PROTEIN; CYSTEINE PROTEINASE; HTT PROTEIN, HUMAN; NEUROPROTECTIVE AGENT;

APOPTOSIS; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL FREE SYSTEM; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; NEUROBLASTOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; WESTERN BLOTTING; BIOSYNTHESIS; DRUG EFFECT; GENETICS; METABOLISM; MUTATION; NERVE CELL; PATHOLOGY; PHAGOSOME; PHYSIOLOGY; TUMOR CELL LINE;

ANTIOXIDANTS; AUTOPHAGY; AUTOPHAGY-RELATED PROTEINS; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; DOPAMINE; HUMANS; HUNTINGTIN PROTEIN; MUTATION; NEURONS; NEUROPROTECTIVE AGENTS; PHAGOSOMES; RESVERATROL;

EID: 85019672258     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2017.05.013     Document Type: Article

References (77)

1. Asanuma, M., Miyazaki, I., Ogawa, N., Dopamine- or L-DOPA-induced neurotoxicity: the role of dopamine quinone formation and tyrosinase in a model of Parkinson's disease. Neurotox. Res. 5 (2003), 165–176.
2. Ay, M., Luo, J., Langley, M., Jin, H., Anantharam, V., Kanthasamy, A., Kanthasamy, A.G., Molecular mechanisms underlying protective effects of quercetin against mitochondrial dysfunction and progressive dopaminergic neurodegeneration in cell culture and MitoPark transgenic mouse models of Parkinson's disease. J. Neurochem., 2017, 10.1111/jnc.14033.
3. Bates, G.P., History of genetic disease: the molecular genetics of Huntington disease - a history. Nat. Rev. Genet. 6:10 (2005), 766–773, 10.1038/nrg1686 Review.
4. Bertelli, A.A., Giovannini, L., Stradi, R., Urien, S., Tillement, J.P., Bertelli, A., Kinetics of trans- and cisresveratrol (3,4′,5-trihydroxystilbene) after red wine oral administration in rats. Int. J. Clin. Pharmacol. Res. 16 (1996), 77–81.
5. Buryanovskyy, L., Fu, Y., Boyd, M., Ma, Y., Hsieh, T.C., Wu, J.M., Zhang, Z., Crystal structure of quinone reductase 2 in complex with resveratrol. Biochemistry 43:36 (2004), 11417–11426.
6. Cagnin, M., Ozzano, M., Bellio, N., Fiorentino, I., Follo, C., Isidoro, C., Dopamine induces apoptosis in APPswe-expressing Neuro2A cells following Pepstatin-sensitive proteolysis of APP in acid compartments. Brain Res. 1471 (2012), 102–117, 10.1016/j.brainres.2012.06.025.
7. Castino, R., Isidoro, C., Murphy, D., Autophagy-dependent cell survival and cell death in an autosomal dominant familial neurohypophyseal diabetes insipidus in vitro model. FASEB J. 19:8 (2005), 1024–1026.
8. Castino, R., Davies, J., Beaucourt, S., Isidoro, C., Murphy, D., Autophagy is a prosurvival mechanism in cells expressing an autosomal dominant familial neurohypophyseal diabetes insipidus mutant vasopressin transgene. FASEB J. 19:8 (2005), 1021–1023.
9. Castino, R., Lazzeri, G., Lenzi, P., Bellio, N., Follo, C., Ferrucci, M., Fornai, F., Isidoro, C., Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine. J. Neurochem. 106:3 (2008), 1426–1439, 10.1111/j.1471-4159.2008.05488.
10. Castino, R., Bellio, N., Follo, C., Murphy, D., Isidoro, C., Inhibition of PI3k class III-dependent autophagy prevents apoptosis and necrosis by oxidative stress in dopaminergic neuroblastoma cells. Toxicol. Sci. 117:1 (2010), 152–162, 10.1093/toxsci/kfq170.
11. Castino, R., Fiorentino, I., Cagnin, M., Giovia, A., Isidoro, C., Chelation of lysosomal iron protects dopaminergic SH-SY5Y neuroblastoma cells from hydrogen peroxide toxicity by precluding autophagy and Akt dephosphorylation. Toxicol. Sci. 123:2 (2011), 523–541, 10.1093/toxsci/kfr179.
12. Cepeda, C., Murphy, K.P., Parent, M., Levine, M.S., The role of dopamine in Huntington's disease. Prog. Brain Res. 211 (2014), 235–254, 10.1016/B978-0-444-63425-2.00010-6 Review.
13. Chao, J., Yu, M.S., Ho, Y.S., Wang, M., Chang, R.C., Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity. Free Radic. Biol. Med. 45:7 (2008), 1019–1026, 10.1016/j.freeradbiomed.2008.07.002.
14. Chen, J.Y., Wang, E.A., Cepeda, C., Levine, M.S., Dopamine imbalance in Huntington's disease: a mechanism for the lack of behavioral flexibility. Front. Neurosci., 7(114), 2013 http://dx.doi.org/10.3389/fnins.2013.00114.
15. Cherra, S.J. 3rd, Dagda, R.K., Chu, C.T., Review: autophagy and neurodegeneration: survival at a cost?. Neuropathol. Appl. Neurobiol. 36:2 (2010), 125–132, 10.1111/j.1365-2990.2010.01062 Review.
16. da Luz, M.H., Peres, I.T., Santos, T.G., Martins, V.R., Icimoto, M.Y., Lee, K.S., Dopamine induces the accumulation of insoluble prion protein and affects autophagic flux. Front. Cell Neurosci., 9, 2015, 12, 10.3389/fncel.2015.00012.
17. D'Alessandro, A., D'Aguanno, S., Cencioni, M.T., Pieroni, L., Diamantini, A., Battistini, L., Longone, P., Spalloni, A., De Laurenzi, V., Bernardini, S., Federici, G., Urbani, A., Protein repertoire impact of Ubiquitin-Proteasome System impairment: insight into the protective role of beta-estradiol. J. Proteomics 75:4 (2012), 1440–1453, 10.1016/j.jprot.2011.11.014.
18. DiFiglia, M., Sapp, E., Chase, K.O., Davies, S.W., Bates, G.P., Vonsattel, J.P., Aronin, N., Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277:5334 (1997), 1990–1993.
19. Dinkova-Kostova, A.T., Talalay, P., Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radic. Biol. Med. 29:3–4 (2000), 231–240 Review.
20. Dutta, D., Mohanakumar, K.P., Tea and Parkinson's disease: constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefits. Neurochem. Int. 89 (2015), 181–190, 10.1016/j.neuint.2015.08.005 Review.
21. Follo, C., Ozzano, M., Mugoni, V., Castino, R., Santoro, M., Isidoro, C., Knock-down of cathepsin D affects the retinal pigment epithelium, impairs swim-bladder ontogenesis and causes premature death in zebrafish. PLoS One, 6(7), 2011, e21908, 10.1371/journal.pone.0021908.
22. Fu, Y., Buryanovskyy, L., Zhang, Z., Quinone reductase 2 is a catechol quinone reductase. J. Biol. Chem. 283:35 (2008), 23829–23835, 10.1074/jbc.M801371200.
23. Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S.R., Jangamreddy, J.R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A.R., Kashani, H.H., Hashemi, M., Owji, A.A., Łos, M.J., Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog. Neurobiol. 112 (2014), 24–49, 10.1016/j.pneurobio.2013.10.004 Review.
24. Gluck, M.R., Zeevalk, G.D., Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases. J. Neurochem. 91:4 (2004), 788–795.
25. Heinrich, M., Wickel, M., Schneider-Brachert, W., Sandberg, C., Gahr, J., Schwandner, R., Weber, T., Saftig, P., Peters, C., Brunner, J., Krönke, M., Schütze, S., Cathepsin D targeted by acid sphingomyelinase-derived ceramide. EMBO J. 18:19 (1999), 5252–5263.
26. Heiseke, A., Aguib, Y., Riemer, C., Baier, M., Schätzl, H.M., Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy. J. Neurochem. 109:1 (2009), 25–34, 10.1111/j.1471-4159.2009.05906.
27. Heng, M.Y., Duong, D.K., Albin, R.L., Tallaksen-Greene, S.J., Hunter, J.M., Lesort, M.J., Osmand, A., Paulson, H.L., Detloff, P.J., Early autophagic response in a novel knock-in model of Huntington disease. Hum. Mol. Genet. 19:19 (2010), 3702–3720, 10.1093/hmg/ddq285.
28. Herrera, A., Muñoz, P., Steinbusch, H.W.M., Segura-Aguilar, J., Are dopamine oxidation metabolites involved in the loss of dopaminergic neurons in the nigrostriatal system in Parkinson's disease?. ACS Chem. Neurosci. 8:4 (2017), 702–711, 10.1021/acschemneuro.7b00034.
29. Ho, D.J., Calingasan, N.Y., Wille, E., Dumont, M., Beal, M.F., Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease. Exp. Neurol. 225:1 (2010), 74–84, 10.1016/j.expneurol.2010.05.006.
30. Isidoro, C., Biagioni, F., Giorgi, F.S., Fulceri, F., Paparelli, A., Fornai, F., The role of autophagy on the survival of dopamine neurons. Curr. Top. Med. Chem. 9:10 (2009), 869–879 Review.
31. Janda, E., Isidoro, C., Carresi, C., Mollace, V., Defective autophagy in Parkinson's disease: role of oxidative stress. Mol. Neurobiol. 46:3 (2012), 639–661, 10.1007/s12035-012-8318-1 Review.
32. Janda, E., Lascala, A., Carresi, C., Parafati, M., Aprigliano, S., Russo, V., Savoia, C., Ziviani, E., Musolino, V., Morani, F., Isidoro, C., Mollace, V., Parkinsonian toxin-induced oxidative stress inhibits basal autophagy in astrocytes via NQO2/quinone oxidoreductase 2: implications for neuroprotection. Autophagy 11:7 (2015), 1063–1080, 10.1080/15548627.2015.1058683.
33. Jia, Z., Zhu, H., Misra, B.R., Mahaney, J.E., Li, Y., Misra, H.P., EPR studies on the superoxide-scavenging capacity of the nutraceutical resveratrol. Mol. Cell Biochem. 313:1–2 (2008), 187–194, 10.1007/s11010-008-9756-y.
34. Khan, M.M., Ahmad, A., Ishrat, T., Khan, M.B., Hoda, M.N., Khuwaja, G., Raza, S.S., Khan, A., Javed, H., Vaibhav, K., Islam, F., Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease. Brain Res. 1328 (2010), 139–151, 10.1016/j.brainres.2010.02.031.
35. Kita, T., Asanuma, M., Miyazaki, I., Takeshima, M., Protective effects of phytochemical antioxidants against neurotoxin-induced degeneration of dopaminergic neurons. J. Pharmacol. Sci. 124:3 (2014), 313–319.
36. Klionsky, D.J., Abdelmohsen, K., Abe, A., et al. Guidelines for the use and interpretation of assays for monitoring autophagy (third ed.). Autophagy 12:1 (2016), 1–222, 10.1080/15548627.2015.1100356.
37. Köchl, R., Hu, X.W., Chan, E.Y., Tooze, S.A., Microtubules facilitate autophagosome formation and fusion of autophagosomes with endosomes. Traffic 7:2 (2006), 129–145.
38. Lee, M.K., Kang, S.J., Poncz, M., Song, K.J., Park, K.S., Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine. Exp. Mol. Med. 39:3 (2007), 376–384.
39. Maher, P., Dargusch, R., Bodai, L., Gerard, P.E., Purcell, J.M., Marsh, J.L., ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. Hum. Mol. Genet. 20:2 (2011), 261–270, 10.1093/hmg/ddq460.
40. Martinez-Vicente, M., Talloczy, Z., Wong, E., Tang, G., Koga, H., Kaushik, S., de Vries, R., Arias, E., Harris, S., Sulzer, D., Cuervo, A.M., Cargo recognition failure is responsible for inefficient autophagy in Huntington's disease. Nat. Neurosci. 13:5 (2010), 567–576, 10.1038/nn.2528.
41. Meiser, J., Weindl, D., Hiller, K., Complexity of dopamine metabolism. Cell Commun. Signal, 11(1), 2013, 34, 10.1186/1478-811X-11-34.
42. Melone, M.A., Jori, F.P., Peluso, G., Huntington's disease: new frontiers for molecular and cell therapy. Curr. Drug Targets 6:1 (2005), 43–56 Review.
43. Mercer, L.D., Kelly, B.L., Horne, M.K., Beart, P.M., Dietary polyphenols protect dopamine neurons from oxidative insults and apoptosis: investigations in primary rat mesencephalic cultures. Biochem. Pharmacol. 69:2 (2005), 339–345 Epub 2004 Nov 23.
44. Miyazaki, I., Asanuma, M., Approaches to prevent dopamine quinone-induced neurotoxicity. Neurochem. Res. 34:4 (2009), 698–706, 10.1007/s11064-008-9843-1.
45. Morani, F., Phadngam, S., Follo, C., Titone, R., Thongrakard, V., Galetto, A., Alabiso, O., Isidoro, C., PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration. Genes Cancer 5:7–8 (2014), 226–239.
46. Muñoz, P., Huenchuguala, S., Paris, I., Segura-Aguilar, J., Dopamine oxidation and autophagy. Park. Dis., 2012, 2012, 920953, 10.1155/2012/920953.
47. Nakatogawa, H., Two ubiquitin-like conjugation systems that mediate membrane formation during autophagy. Essays Biochem. 55 (2013), 39–50, 10.1042/bse0550039 Review.
48. Naoi, M., Maruyama, W., Yi, H., Yamaoka, Y., Shamoto-Nagai, M., Akao, Y., Gerlach, M., Tanaka, M., Riederer, P., Neuromelanin selectively induces apoptosis in dopaminergic SH-SY5Y cells by deglutathionylation in mitochondria: involvement of the protein and melanin component. J. Neurochem. 105:6 (2008), 2489–2500, 10.1111/j.1471-4159.2008.05329.x.
49. Paris, I., Perez-Pastene, C., Cardenas, S., Iturriaga-Vasquez, P., Muñoz, P., Couve, E., Caviedes, P., Segura-Aguilar, J., Aminochrome induces disruption of actin, alpha-, and beta-tubulin cytoskeleton networks in substantia-nigra-derived cell line. Neurotox. Res. 18:1 (2010), 82–92, 10.1007/s12640-009-9148-4.
50. Parker, J.A., Arango, M., Abderrahmane, S., Lambert, E., Tourette, C., Catoire, H., Néri, C., Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37:4 (2005), 349–350.
51. Pattingre, S., Bauvy, C., Carpentier, S., Levade, T., Levine, B., Codogno, P., Role of JNK1-dependent Bcl-2 phosphorylation in ceramide-induced macroautophagy. J. Biol. Chem. 284 (2009), 2719–2728.
52. Pavese, N., Andrews, T.C., Brooks, D.J., Ho, A.K., Rosser, A.E., Barker, R.A., Robbins, T.W., Sahakian, B.J., Dunnett, S.B., Piccini, P., Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: a PET study. Brain 126:Pt5 (2003), 1127–1135.
53. Petersén, A., Larsen, K.E., Behr, G.G., Romero, N., Przedborski, S., Brundin, P., Sulzer, D., Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Hum. Mol. Genet. 10:12 (2001), 1243–1254.
54. Phadngam, S., Castiglioni, A., Ferraresi, A., Morani, F., Follo, C., Isidoro, C., PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells. Oncotarget 7:51 (2016), 84999–85020, 10.18632/oncotarget.13113.
55. Qin, Z.H., Wang, Y., Kegel, K.B., Kazantsev, A., Apostol, B.L., Thompson, L.M., Yoder, J., Aronin, N., DiFiglia, M., Autophagy regulates the processing of amino terminal huntingtin fragments. Hum. Mol. Genet. 2:24 (2003), 3231–3244.
56. Richard, T., Pawlus, A.D., Iglésias, M.L., Pedrot, E., Waffo-Teguo, P., Mérillon, J.M., Monti, J.P., Neuroprotective properties of resveratrol and derivatives. Ann. N. Y. Acad. Sci. 1215 (2011), 103–108, 10.1111/j.1749-6632.2010.05865.x Review.
57. Roscic, A., Baldo, B., Crochemore, C., Marcellin, D., Paganetti, P., Induction of autophagy with catalytic mTOR inhibitors reduces huntingtin aggregates in a neuronal cell model. J. Neurochem. 119:2 (2011), 398–407, 10.1111/j.1471-4159.2011.07435.
58. Rubinzstein, D.C., Lessons from animal models of Huntington's disease. Trends Genet. 18:4 (2002), 202–209 Review.
59. Sarkar, S., Perlstein, E.O., Imarisio, S., Pineau, S., Cordenier, A., Maglathlin, R.L., Webster, J.A., Lewis, T.A., O'Kane, C.J., Schreiber, S.L., Rubinsztein, D.C., Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 3:6 (2007), 331–338.
60. Sarkar, S., Krishna, G., Imarisio, S., Saiki, S., O'Kane, C.J., Rubinsztein, D.C., A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. Hum. Mol. Genet. 17:2 (2008), 170–178.
61. Sarkar, S., Rubinsztein, D.C., Huntington's disease: degradation of mutant huntingtin by autophagy. FEBS J. 275:17 (2008), 4263–4270, 10.1111/j.1742-4658.2008.06562 Review.
62. Scherz-Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., Elazar, Z., Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26:7 (2007), 1749–1760 Apr 4.
63. Skytte Rasmussen, M., Mouilleron, S., Kumar Shrestha, B., Wirth, M., Lee, R., Bowitz Larsen, K., Abudu Princely, Y., O'Reilly, N., Sjøttem, E., Tooze, S.A., Lamark, T., Johansen, T., ATG4B contains a C-terminal LIR motif important for binding and efficient cleavage of mammalian orthologs of yeast Atg8. Autophagy 15 (2017), 1–20, 10.1080/15548627.2017.1287651.
64. Slobodkin, M.R., Elazar, Z., The Atg8 family: multifunctional ubiquitin-like key regulators of autophagy. Essays Biochem. 55 (2013), 51–64, 10.1042/bse0550051 Review.
65. Sulzer, D., Bogulavsky, J., Larsen, K.E., Behr, G., Karatekin, E., Kleinman, M.H., Turro, N., Krantz, D., Edwards, R.H., Greene, L.A., Zecca, L., Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc. Natl. Acad. Sci. U. S. A. 97:22 (2000), 11869–11874.
66. Sun, D., Yue, Q., Guo, W., Li, T., Zhang, J., Li, G., Liu, Z., Sun, J., Neuroprotection of resveratrol against neurotoxicity induced by methamphetamine in mouse mesencephalic dopaminergic neurons. Biofactors 41:4 (2015), 252–260, 10.1002/biof.1221.
67. Trincheri, N.F., Nicotra, G., Follo, C., Castino, R., Isidoro, C., Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D. Carcinogenesis 28:5 (2007), 922–931.
68. Vidoni, C., Castiglioni, A., Seca, C., Secomandi, E., Melone, M.A., Isidoro, C., Dopamine exacerbates mutant Huntingtin toxicity via oxidative-mediated inhibition of autophagy in SH-SY5Y neuroblastoma cells: beneficial effects of anti-oxidant therapeutics. Neurochem. Int. 101 (2016), 132–143, 10.1016/j.neuint.2016.11.003.
69. Vidoni, C., Follo, C., Savino, M., Melone, M.A., Isidoro, C., The role of cathepsin D in the pathogenesis of human neurodegenerative disorders. Med. Res. Rev. 36:5 (2016), 845–870, 10.1002/med.21394 Review.
70. Vingtdeux, V., Giliberto, L., Zhao, H., Chandakkar, P., Wu, Q., Simon, J.E., Janle, E.M., Lobo, J., Ferruzzi, M.G., Davies, P., Marambaud, P., AMP-activated protein kinase signalling activation by resveratrol modulates amyloid-beta peptide metabolism. J. Biol. Chem. 285:12 (2010), 9100–9113, 10.1074/jbc.M109.060061.
71. Vonsattel, J.P., Myers, R.H., Stevens, T.J., Ferrante, R.J., Bird, E.D., Richardson, E.P. Jr., Neuropathological classification of Huntington's disease. J. Neuropathol. Exp. Neurol., 44(6), 1985, 559e577.
72. Wang, M., Yu, T., Zhu, C., Sun, H., Qiu, Y., Zhu, X., Li, J., Resveratrol triggers protective autophagy through the ceramide/Akt/mTOR pathway in melanoma B16 cells. Nutr. Cancer 66:3 (2014), 435–440, 10.1080/01635581.2013.878738.
73. Wang, W., Le, W.D., Pan, T., Stringer, J.L., Jaiswal, A.K., Association of NRH:quinone oxidoreductase 2 gene promoter polymorphism with higher gene expression and increased susceptibility to Parkinson's disease. J. Gerontol. A Biol. Sci. Med. Sci. 63:2 (2008), 127–134.
74. Wild, P., McEwan, D.G., Dikic, I., The LC3 interactome at a glance. J. Cell Sci. 127:Pt 1 (2014), 3–9, 10.1242/jcs.140426 Review.
75. Wu, K., Knox, R., Sun, X.Z., Joseph, P., Jaiswal, A.K., Zhang, D., Deng, P.S., Chen, S., Catalytic properties of NAD-(P)H:quinone oxidoreductase-2 (NQ02), a dihydronicotinamide riboside dependent oxidoreductase. Arch. Biochem. Biophys. 347 (1997), 221–228.
76. Zebrakovská I., Máša, M., Srp, J., Horn, M., Vávrová K., Mareš M., Complex modulation of peptidolytic activity of cathepsin D by sphingolipids. Biochim. Biophys. Acta 1811:12 (2011), 1097–1104, 10.1016/j.bbalip.2011.09.005.
77. Zhao, H., Chen, S., Gao, K., Zhou, Z., Wang, C., Shen, Z., Guo, Y., Li, Z., Wan, Z., Liu, C., Mei, X., Resveratrol protects against spinal cord injury by activating autophagy and inhibiting apoptosis mediated by the SIRT1/AMPK signaling pathway. Neuroscience 348 (2017), 241–251, 10.1016/j.neuroscience.2017.02.027.